162 related articles for article (PubMed ID: 21656308)
1. The effects of morphine-neostigmine and secretin provocation on pancreaticobiliary morphology in healthy subjects: a randomized, double-blind crossover study using serial MRCP.
Chowdhury AH; Humes DJ; Pritchard SE; Marciani L; Gowland PA; Simpson J; Lobo DN
World J Surg; 2011 Sep; 35(9):2102-9. PubMed ID: 21656308
[TBL] [Abstract][Full Text] [Related]
2. Prospective comparison of secretin-stimulated magnetic resonance cholangiopancreatography with manometry in the diagnosis of sphincter of Oddi dysfunction types II and III.
Pereira SP; Gillams A; Sgouros SN; Webster GJ; Hatfield AR
Gut; 2007 Jun; 56(6):809-13. PubMed ID: 17005767
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic yield of ERCP and secretin-enhanced MRCP and EUS in patients with acute recurrent pancreatitis of unknown aetiology.
Mariani A; Arcidiacono PG; Curioni S; Giussani A; Testoni PA
Dig Liver Dis; 2009 Oct; 41(10):753-8. PubMed ID: 19278909
[TBL] [Abstract][Full Text] [Related]
4. MRCP-secretin test-guided management of idiopathic recurrent pancreatitis: long-term outcomes.
Testoni PA; Mariani A; Curioni S; Zanello A; Masci E
Gastrointest Endosc; 2008 Jun; 67(7):1028-34. PubMed ID: 18179795
[TBL] [Abstract][Full Text] [Related]
5. Secretin MRCP and endoscopic pancreatic manometry in the evaluation of sphincter of Oddi function: a comparative pilot study in patients with idiopathic recurrent pancreatitis.
Mariani A; Curioni S; Zanello A; Passaretti S; Masci E; Rossi M; Del Maschio A; Testoni PA
Gastrointest Endosc; 2003 Dec; 58(6):847-52. PubMed ID: 14652551
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic ductal abnormalities documented by secretin-enhanced MRCP in asymptomatic subjects with chronic pancreatic hyperenzymemia.
Testoni PA; Mariani A; Curioni S; Giussani A; Masci E
Am J Gastroenterol; 2009 Jul; 104(7):1780-6. PubMed ID: 19436288
[TBL] [Abstract][Full Text] [Related]
7. Visualization of pancreaticobiliary reflux in anomalous pancreaticobiliary junction by secretin-stimulated dynamic magnetic resonance cholangiopancreatography.
Hosoki T; Hasuike Y; Takeda Y; Michita T; Watanabe Y; Sakamori R; Tokuda Y; Yutani K; Sai C; Mitomo M
Acta Radiol; 2004 Jul; 45(4):375-82. PubMed ID: 15323388
[TBL] [Abstract][Full Text] [Related]
8. Pitfalls of MRCP in the diagnosis of pancreaticobiliary maljunction.
Kamisawa T; Okamoto T
JOP; 2004 Nov; 5(6):488-90. PubMed ID: 15536287
[TBL] [Abstract][Full Text] [Related]
9. Objective evaluation of ampullary stenosis with ultrasonography and pancreatic stimulation.
Warshaw AL; Simeone J; Schapiro RH; Hedberg SE; Mueller PE; Ferrucci JT
Am J Surg; 1985 Jan; 149(1):65-72. PubMed ID: 3881057
[TBL] [Abstract][Full Text] [Related]
10. Prospective comparison of secretin-stimulated MRCP with manometry in the diagnosis of sphincter of Oddi dysfunction types II and III.
Baillie J; Kimberly J
Gut; 2007 Jun; 56(6):742-4. PubMed ID: 17519477
[TBL] [Abstract][Full Text] [Related]
11. Comparison of secretin-stimulated magnetic resonance pancreatography and manometry results in patients with suspected sphincter of oddi dysfunction.
Aisen AM; Sherman S; Jennings SG; Fogel EL; Li T; Cheng CL; Devereaux BM; McHenry L; Watkins JL; Lehman GA
Acad Radiol; 2008 May; 15(5):601-9. PubMed ID: 18423317
[TBL] [Abstract][Full Text] [Related]
12. Definition of age-dependent reference values for the diameter of the common bile duct and pancreatic duct on MRCP: a population-based, cross-sectional cohort study.
Beyer G; Kasprowicz F; Hannemann A; Aghdassi A; Thamm P; Volzke H; Lerch MM; Kühn JP; Mayerle J
Gut; 2023 Sep; 72(9):1738-1744. PubMed ID: 36828626
[TBL] [Abstract][Full Text] [Related]
13. Neostigmine® Improves Pancreatic Duct Visualization in Magnetic Resonance Cholangiopancreatography and Could Be a Cheap Alternative for Secretin.
Toledo PF; Cárdenas G; Berger Z; Simian D; Araya F
Turk J Gastroenterol; 2022 Aug; 33(8):704-709. PubMed ID: 35946885
[TBL] [Abstract][Full Text] [Related]
14. Correlation between secretin-enhanced MRCP findings and histopathologic severity of chronic pancreatitis in a cat model.
Zhang TT; Wang L; Wang DB; Huang ZJ; Li YH; Lu JP
Pancreatology; 2013; 13(5):491-7. PubMed ID: 24075513
[TBL] [Abstract][Full Text] [Related]
15. Morphine- and glucagon-augmented magnetic resonance cholangiopancreatography to evaluate living liver donors.
Mo YH; Liang PC; Ho MC; Lee PH; Jaw FS; Peng SS
Liver Transpl; 2009 Sep; 15(9):1021-7. PubMed ID: 19718648
[TBL] [Abstract][Full Text] [Related]
16. Secretin-enhanced MR cholangiopancreatography: spectrum of findings.
Tirkes T; Sandrasegaran K; Sanyal R; Sherman S; Schmidt CM; Cote GA; Akisik F
Radiographics; 2013; 33(7):1889-906. PubMed ID: 24224585
[TBL] [Abstract][Full Text] [Related]
17. [Secretin-stimulating MRCP: the diagnosis of pancreaticobiliary reflux].
Motosugi U; Ichikawa T; Araki T
Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Nov; 63(9):591-3. PubMed ID: 14699872
[TBL] [Abstract][Full Text] [Related]
18. Oddi sphincter and common channel: evaluation with pharmacodynamic MR cholangiopancreatography using fatty meal and secretin stimulation.
Koike S; Ito K; Honjo K; Takano K; Yasui M; Matsunaga N
Radiat Med; 2000; 18(2):115-22. PubMed ID: 10888044
[TBL] [Abstract][Full Text] [Related]
19. Does secretin add value in pediatric magnetic resonance cholangiopancreatography?
Trout AT; Podberesky DJ; Serai SD; Ren Y; Altaye M; Towbin AJ
Pediatr Radiol; 2013 Apr; 43(4):479-86. PubMed ID: 23184093
[TBL] [Abstract][Full Text] [Related]
20. Secretin-Enhanced MRCP: How and Why-
Swensson J; Zaheer A; Conwell D; Sandrasegaran K; Manfredi R; Tirkes T
AJR Am J Roentgenol; 2021 May; 216(5):1139-1149. PubMed ID: 33263419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
